Page last updated: 2024-11-06

prednisolone and Extensively Drug-Resistant Tuberculosis

prednisolone has been researched along with Extensively Drug-Resistant Tuberculosis in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Extensively Drug-Resistant Tuberculosis: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alsleben, N1
Garcia-Prats, AJ1
Hesseling, AC1
Willemse, M1
Donald, PR1
Schaaf, HS1

Other Studies

1 other study available for prednisolone and Extensively Drug-Resistant Tuberculosis

ArticleYear
Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous Meningitis.
    Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:3

    Topics: Anti-Inflammatory Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child, Pres

2015